S100A8 and lung carcinoma: To determine effects of S100A8 on orthotopic lung cancer engraftment, mice were administered a single intranasal dose of S100A8 or HBSS (control), and whole lungs harvested 20 days post-LLC cell implantation, the time when advanced lung disease was evident.